1. Home
  2. KSCP vs SCYX Comparison

KSCP vs SCYX Comparison

Compare KSCP & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KSCP
  • SCYX
  • Stock Information
  • Founded
  • KSCP 2013
  • SCYX 1999
  • Country
  • KSCP United States
  • SCYX United States
  • Employees
  • KSCP N/A
  • SCYX N/A
  • Industry
  • KSCP Telecommunications Equipment
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KSCP Telecommunications
  • SCYX Health Care
  • Exchange
  • KSCP Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • KSCP 35.9M
  • SCYX 28.5M
  • IPO Year
  • KSCP 2022
  • SCYX 2014
  • Fundamental
  • Price
  • KSCP $7.36
  • SCYX $0.71
  • Analyst Decision
  • KSCP Strong Buy
  • SCYX
  • Analyst Count
  • KSCP 3
  • SCYX 0
  • Target Price
  • KSCP $15.67
  • SCYX N/A
  • AVG Volume (30 Days)
  • KSCP 408.8K
  • SCYX 145.5K
  • Earning Date
  • KSCP 08-13-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • KSCP N/A
  • SCYX N/A
  • EPS Growth
  • KSCP N/A
  • SCYX N/A
  • EPS
  • KSCP N/A
  • SCYX N/A
  • Revenue
  • KSCP $11,468,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • KSCP $16.17
  • SCYX $463.61
  • Revenue Next Year
  • KSCP $39.02
  • SCYX $310.80
  • P/E Ratio
  • KSCP N/A
  • SCYX N/A
  • Revenue Growth
  • KSCP N/A
  • SCYX N/A
  • 52 Week Low
  • KSCP $2.45
  • SCYX $0.66
  • 52 Week High
  • KSCP $28.57
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • KSCP 69.42
  • SCYX 38.69
  • Support Level
  • KSCP $6.33
  • SCYX $0.67
  • Resistance Level
  • KSCP $7.32
  • SCYX $0.75
  • Average True Range (ATR)
  • KSCP 0.49
  • SCYX 0.04
  • MACD
  • KSCP 0.25
  • SCYX 0.00
  • Stochastic Oscillator
  • KSCP 81.65
  • SCYX 33.06

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: